ReviewPublished 8 October 2026Neuromodulatory interventions for Alzheimer’s diseaseRuofan Wang · Botao Zhu · Qingda Guo · Jun Steed Huang · Wandong ZhangFrontiers in Aging Neurosciencedoi 10.3389/fnagi.2026.1925914
ReviewPublished 5 October 2026Ethical challenges in the clinical translation of anti-amyloid monoclonal antibodies for Alzheimer’s disease: a scoping reviewAlexandra Wicker · Amanda Courtright-Lim · Jon TilburtFrontiers in Psychiatrydoi 10.3389/fpsyt.2026.1953954
